Portal announces new product, PRIME Nexus

January 2025 – Portal Instruments, a leader in innovative drug delivery technology, recently announced the launch of PRIME Nexus, a cutting-edge reusable electronic injector designed to enhance the administration of injectable medications while helping partners meet their sustainability goals.

Author: 
Published on: 
January 16, 2025

Cambridge, MA. - January 7, 2025 – Portal Instruments, a leader in innovative drug delivery technology, recently announced the launch of PRIME Nexus, a cutting-edge reusable injector designed to enhance the administration of injectable medications. Built on Portal’s robust platform technology, the PRIME Nexus is a needle-based device designed to be compatible with standard primary containers, including 1mL pre-filled syringes (PFS), 2.25mL PFS, and 3mL cartridges.

The PRIME Nexus represents a significant advancement in drug delivery, offering precise control and versatility for a wide range of therapies. This innovative device is poised to be a game-changer for pharmaceutical companies and patients alike, offering several key advantages:

  • Precise control over injection time: The PRIME Nexus allows for precise control over the injection duration, enabling tailored delivery profiles for various medications.
  • Seamlessly handles larger volumes: Designed to accommodate larger volumes, the PRIME Nexus expands the possibilities for therapies requiring higher doses.
  • Efficiently accommodates low to high viscosities: The device’s robust design efficiently handles a wide range of viscosities, making it compatible with diverse drug formulations.

“We are thrilled to introduce PRIME Nexus, a reusable injector that combines precision, versatility, and ease of use,” said Patrick Anquetil, CEO at Portal Instruments. “This device represents a new way forward in drug delivery, offering pharmaceutical companies a powerful tool to enhance the patient experience while reducing medical waste.”

The PRIME Nexus is designed to seamlessly integrate into existing manufacturing and packaging processes, streamlining the development and commercialization of new injectable therapies. Its compatibility with standard primary containers further simplifies integration and reduces development timelines.

Portal Instruments will showcase the PRIME Nexus device at Pharmapack and other key industry events. Attendees will have the opportunity to see the device in action and discuss feasibility or development studies for this reusable injector.

About Portal Instruments:

Portal Instruments is a privately held medical device company focused on developing and commercializing innovative drug delivery platform technologies to transform the administration of injectable medications. Portal's goal is to improve patient experience, adherence, and outcomes by providing advanced delivery solutions.

Other news

View more news